These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Effects of YJA20379-4 on gastric secretion, Helicobacter pylori growth and various gastric and duodenal lesions in rats. Woo TW; Chang MS; Chung YK; Kim KB; Sohn SK; Kim SG; Choi WS Biol Pharm Bull; 1998 May; 21(5):449-55. PubMed ID: 9635498 [TBL] [Abstract][Full Text] [Related]
30. Role of gastric mucosal eicosanoid production in the cytoprotection induced by nitecapone. Aho PA; Lindén IB Scand J Gastroenterol; 1992; 27(2):134-8. PubMed ID: 1561527 [TBL] [Abstract][Full Text] [Related]
31. Gastroprotective agents in mucosal defense against Helicobacter pylori. Slomiany BL; Murty VL; Piotrowski J; Slomiany A Gen Pharmacol; 1994 Sep; 25(5):833-41. PubMed ID: 7835626 [TBL] [Abstract][Full Text] [Related]
32. Gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide: down-regulation of nitric oxide synthase-2 and caspase-3 by sulglycotide. Slomiany BL; Piotrowski J; Slomiany A Biochem Biophys Res Commun; 1999 Jul; 261(1):15-20. PubMed ID: 10405316 [TBL] [Abstract][Full Text] [Related]
33. Inhibition of Helicobacter pylori glycosulfatase activity towards human gastric sulfomucin by a gastroprotective agent, sulglycotide. Murty VL; Piotrowski J; Czajkowski A; Slomiany A; Slomiany BL Gen Pharmacol; 1993 Nov; 24(6):1463-6. PubMed ID: 8112521 [TBL] [Abstract][Full Text] [Related]
34. Rebamipide, a novel antiulcer agent, attenuates Helicobacter pylori induced gastric mucosal cell injury associated with neutrophil derived oxidants. Suzuki M; Miura S; Mori M; Kai A; Suzuki H; Fukumura D; Suematsu M; Tsuchiya M Gut; 1994 Oct; 35(10):1375-8. PubMed ID: 7959190 [TBL] [Abstract][Full Text] [Related]
35. In vitro susceptibility of Helicobacter pylori to nitecapone. Rautelin H; Renkonen OV; Kosunen TV Eur J Clin Microbiol Infect Dis; 1992 Mar; 11(3):274-5. PubMed ID: 1597212 [No Abstract] [Full Text] [Related]
36. Effect of methanolic extract of Terminalia arjuna against Helicobacter pylori 26695 lipopolysaccharide-induced gastric ulcer in rats. Devi RS; Kist M; Vani G; Devi CS J Pharm Pharmacol; 2008 Apr; 60(4):505-14. PubMed ID: 18380924 [TBL] [Abstract][Full Text] [Related]
37. Helicobacter pylori lipopolysaccharide effect on the synthesis and secretion of gastric sulfomucin. Liau YH; Lopez RA; Slomiany A; Slomiany BL Biochem Biophys Res Commun; 1992 May; 184(3):1411-7. PubMed ID: 1590801 [TBL] [Abstract][Full Text] [Related]
38. Helicobacter pylori lipopolysaccharide interacts with TFF1 in a pH-dependent manner. Reeves EP; Ali T; Leonard P; Hearty S; O'Kennedy R; May FE; Westley BR; Josenhans C; Rust M; Suerbaum S; Smith A; Drumm B; Clyne M Gastroenterology; 2008 Dec; 135(6):2043-54, 2054.e1-2. PubMed ID: 18848942 [TBL] [Abstract][Full Text] [Related]
39. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin. Slomiany BL; Piotrowski J; Slomiany A J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571 [TBL] [Abstract][Full Text] [Related]
40. Ecabet sodium inhibits Helicobacter pylori lipopolysaccharide-induced activation of NADPH oxidase 1 or apoptosis of guinea pig gastric mucosal cells. Kusumoto K; Kawahara T; Kuwano Y; Teshima-Kondo S; Morita K; Kishi K; Rokutan K Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G300-7. PubMed ID: 15458921 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]